Login to Your Account

FDA Gives Thumbs Down to Nuvigil for Jet Lag

By Catherine Shaffer

Tuesday, December 28, 2010
Cephalon Inc. will not pursue approval of its sleep disorder drug Nuvigil (armodafinil) for jet lag following a second complete response letter from the FDA.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription